TotalMarketCap

Enanta Pharmaceuticals

ENTANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$294.167 M

$10.10 -5.16%

Close of 6 Nov 2026

As of 6 Nov 2026, Enanta Pharmaceuticals (ENTA) has a market capitalization of $294.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$65.3M

#2634 by revenue

Earnings

-$81.9M

Loss-making

Shares outstanding

29,125,402

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #218Galectin TherapeuticsGALT$301.2M
  2. #219Emergent BioSolutionsEBS$300.0M
  3. #220Enanta PharmaceuticalsENTA$294.2M
  4. #221Prelude TherapeuticsPRLD$283.7M
  5. #222Fulcrum TherapeuticsFULC$281.5M

What if Enanta Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$969,493.02

Per share 95,989× higher

Bitcoin $1.53T

$52,457.58

Per share 5,194× higher

Apple $5.02T

$172,213.34

Per share 17,051× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Enanta Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.